| Filing date | Description | Form | View |
|---|---|---|---|
| D | View HTML | ||
| D | View HTML | ||
| D/A | View HTML | ||
| D | View HTML | ||
| D | View HTML | ||
| D | View HTML | ||
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
DRS | View HTML | |
UPLOAD |
UPLOAD | View HTML | |
Amendment to a previously filed DRS |
DRS/A | View HTML | |
Registration statement for face-amount certificate companies |
S-1 | View HTML |
Data provided by Kaleidoscope.
2022
2021
Thursday, May 4, 2023, at 9:00 AM Pacific Time
The 2023 Annual Meeting of Stockholders of Nurix Therapeutics, Inc. (“Nurix” or the “Company”) was held on Thursday, May 4, 2023.
Stockholders of record of Nurix common stock as of the close of business on March 10, 2023, were entitled to vote at the meeting. A replay of the webcast of the meeting will be accessible by visiting www.virtualshareholdermeeting.com/NRIX2023.
The date, time and location of our 2024 Annual Meeting of Stockholders will be announced in our annual proxy statement filed with the SEC and will be available at the SEC Filings page found within the “Investors” section of our website.
'